Yüklüyor......
The rationale for including immune checkpoint inhibition into multimodal primary treatment concepts of head and neck cancer
BACKGROUND: Treatment of locally advanced squamous cell carcinomas of the head and neck (SCCHN) remains unsatisfactory. Although the addition of concurrent radiochemotherapy (RCT) or the combination of radiotherapy with blockade of the epidermal growth factor receptor (EGFR) have improved outcomes o...
Kaydedildi:
| Yayımlandı: | Cancers Head Neck |
|---|---|
| Asıl Yazarlar: | , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BioMed Central
2016
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6460729/ https://ncbi.nlm.nih.gov/pubmed/31093338 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s41199-016-0009-6 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|